InnoCare Pharma News

Nuochengjianhua Investor Relations Activity Record List (November 12, 2024)

Nov 12 17:36

Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes

Nov 6 00:00

Hong Kong Stock Announcement: Monthly Statement of Changes in Securities

Nov 6 00:00

Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024

Nov 5 00:00

Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024

Nov 5 00:00

Nuocheng Jianhua: Hong Kong Stock Announcement: Date of Board Meeting

Oct 29 00:00

Hong Kong Stock Announcement: Date of Board Meeting

Oct 29 00:00

Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes

Oct 9 00:00

Hong Kong Stock Announcement: Monthly Statement of Changes in Securities

Oct 9 00:00

Nuocheng Jianhua: Hong Kong Stock Announcement: List of Directors and Their Roles and Functions

Sep 26 00:00

Hong Kong Stock Announcement: 2024 Interim Report

Sep 25 00:00

China International Finance Corporation\'s inspection opinions on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd.\'s strategic placement and listing circulation of restricted shares

Sep 11 00:00

Hong Kong Stock Announcement: Monthly Statement of Changes in Securities

Sep 5 00:00

China International Finance Corporation\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Nuochengjianhua Pharmaceutical Co., Ltd.

Sep 5 00:00

Hong Kong Stock Announcement: Next Day Disclosure Statement

Aug 31 00:00

Special report on the use of funds raised in the first half of 2024 by Innocare Pharmaceutical Co., Ltd.

Aug 21 00:00

Announcement from Innocare Pharmaceuticals Co., Ltd. on the 2024 mid-year performance briefing.

Aug 14 00:00

Legal Opinion of Fangda Law Firm regarding the 2024 Shareholders Annual Meeting of Innocare Pharma Limited, Shanghai.

Jun 28 00:00

Announcement of the Board of Directors of Innocare Pharmaceutical Co., Ltd.

Jun 26 00:00

Shanghai Rongzheng Enterprise Consulting Services (Group) Co., Ltd.'s independent financial advisor report on the first vesting period of Innocare Pharmaceutical Co., Ltd.'s 2023 STAR Market restricted stock incentive plan that meets the attribution conditions for the first time.

Jun 26 00:00